Montag & Associates’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-17,154
Closed -$883K 237
2015
Q3
$883K Sell
17,154
-65,751
-79% -$4.36M 0.14% 137
2015
Q2
$6.58M Buy
82,905
+13,204
+19% +$1.12M 0.96% 25
2015
Q1
$5.73M Buy
69,701
+18,761
+37% +$1.57M 0.83% 36
2014
Q4
$4.52M Buy
50,940
+46,840
+1,142% +$4.24M 0.68% 49
2014
Q3
$402K Buy
4,100
+738
+22% +$82.9K 0.07% 188
2014
Q2
$431K Buy
3,362
+12
+0.4% +$1.5K 0.07% 188
2014
Q1
$411K Buy
3,350
+378
+13% +$43.4K 0.07% 178
2013
Q4
$326K Buy
2,972
+148
+5% +$14.8K 0.06% 184
2013
Q3
$275K Buy
2,824
+349
+14% +$32.2K 0.05% 192
2013
Q2
$222K Buy
+2,475
New +$204K 0.05% 193

Other funds holding ENOV

Montag & Associates's ENOV Position: Q4 2015 in Review

Montag & Associates sold out of Enovis (ENOV) in Q4 2015, closing a stake of 17,154 shares — an estimated $883K sold.

Montag & Associates first reported a position in ENOV in Q2 2013 and held it in 10 quarters. The position peaked at $6.58M in Q2 2015. 205 funds tracked by Wall St. Rank hold ENOV as of Q4 2015.

  • Montag & Associates reported no remaining Enovis position as of Q4 2015 after selling out during the quarter.
  • Montag & Associates sold 17,154 Enovis shares in Q4 2015, an estimated $883K.
  • Montag & Associates first reported a position in Enovis in Q2 2013 and held it in 10 quarters.
  • Montag & Associates's Enovis position peaked at $6.58M in Q2 2015.
  • 205 funds tracked by Wall St. Rank held Enovis as of Q4 2015.

Based on Montag & Associates's 13F filing for Q4 2015, filed 11 Feb 2016.